Atlas Trials

Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies

Clinical trial NCT01442194 · COMPLETED

Trial details

NCT number
NCT01442194
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Study type
OBSERVATIONAL
Multiple Sclerosis
Start date
2011-08-01
Primary completion
2020-07-10
Enrollment
3076

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.